Granted Patent B2

US 12,435,361 · App. 16/596,587 · Granted Oct 7, 2025

Inventors: Joseph M. Beechem (Eugene, OR); Gordon B. Mills (Houston, TX); Charles Warren (Bremerton, WA); Chris Merritt (Seattle, WA); Jaemyeong Jung (Bellevue, WA); Dwayne L. Dunaway (Seattle, WA); Scott Crowder (Seattle, WA)

Assignees: Bruker Spatial Biology, Inc.; Board of Regents, The University of Texas System

C12Q1/6832C12Q1/6804C12Q1/6841G01N33/54306G01N33/58G01N2458/10

Abstract

Claims (24)

1. A method comprising:

(1) contacting at least one protein target in a tissue sample with at least one probe comprising a target-binding domain, a signal oligonucleotide and a photo-cleavable motif located between the target binding domain and the signal oligonucleotide, wherein the tissue sample is immersed in fluid;

(2) illuminating a specific location of the immersed tissue sample with light sufficient to release the signal oligonucleotide into the fluid;

(3) collecting the released signal oligonucleotide by aspirating the fluid proximal to the specific location that was illuminated, wherein the fluid proximal to the specific location that was illuminated is located directly above the specific location that was illuminated, wherein the aspiration is performed using a capillary tube no more than 100 μm above the immersed tissue sample; and

(4) identifying the released signal oligonucleotide, thereby detecting the at least one protein target in the specific location of the tissue sample that was illuminated.

2. The method of claim 1 , wherein detecting comprises a polymerase reaction, a reverse transcriptase reaction, hybridization to an oligonucleotide microarray, mass spectrometry, hybridization to a fluorescent molecular beacon, a sequencing reaction, or the use of molecular barcodes.

3. The method of claim 1 , wherein detecting comprises determining the identity and the abundance of the at least one protein target.

4. The method of claim 1 , wherein the at least one protein target comprises at least two distinct protein targets or at least two copies of the same protein target.

5. The method of claim 4 , wherein detecting comprises comparing the abundance of each distinct protein target.

6. The method of claim 1 , further comprising repeating at least steps (2)-(4) on at least a second specific location of the tissue sample.

7. The method of claim 6 , wherein detecting comprises comparing the abundance of the at least one protein target in the specific location and in the at least second specific location.

8. The method of claim 6 , wherein the specific location and the at least second specific location comprise the same cell type or distinct cell types.

9. The method of claim 1 , wherein the tissue sample is directly immobilized to a surface or is indirectly immobilized to a surface.

10. The method of claim 1 , wherein the tissue sample is a 2 to 1000 μm thick tissue section.

11. The method of claim 1 , wherein the tissue sample is obtained from a formalin-fixed paraffin embedded (FFPE) sample.

12. The method of claim 1 , wherein the tissue sample is fixed or unfixed.

13. The method of claim 1 , wherein the tissue sample is stained or labeled thereby allowing visualization of a subcellular, cellular, or tissue-related structure in the stained or labeled tissue sample.

14. The method of claim 1 , wherein the signal oligonucleotide is a single-stranded nucleic acid or a partially double-stranded nucleic acid.

15. The method of claim 1 , wherein a negative purification is used to remove intact probe molecules from the released signal oligonucleotides, wherein the negative purification comprises an affinity purification comprising contacting an intact probe with an immobilized oligonucleotide that is complementary to a portion of the intact probe or an immobilized antibody or protein-binding motif that recognizes and binds to a portion of the intact probe, wherein the intact probe's target binding domain comprises a universal purification tag or sequence that is partially complementary to the immobilized oligonucleotide or is capable of being recognized or bound by the immobilized antibody or protein-binding motif.

16. The method of claim 1 , wherein the illumination is provided by a light source selected from the group consisting of an arc-lamp, a laser, a focused UV light source, and light emitting diode (LED).

17. The method of claim 1 , wherein the illumination source is UV light.

18. The method of claim 1 , wherein the target-binding domain is selected from the group consisting of an antibody, a peptide, an aptamer, and a peptoid.

19. The method of claim 1 , wherein the protein target is an intact protein, a plurality of polypeptides, a polypeptide, or a peptide.

20. The method of claim 1 , wherein the method further comprises illuminating a region of interest using a laser scanning device or a digital mirror device (DMD).

Assignments (8)

Continuity (6)

References Cited (185)